Trademark: 79363664
Word
STIPE THERAPEUTICS
Status
Registered
Status Code
700
Status Date
Tuesday, April 2, 2024
Serial Number
79363664
Registration Number
7341867
Registration Date
Tuesday, April 2, 2024
Mark Type
4000
Filing Date
Wednesday, June 29, 2022
Published for Opposition
Tuesday, January 16, 2024

Trademark Owner History
STIPE Therapeutics ApS - Original Registrant

Classifications
5 Pharmaceutical preparations for the prevention of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases, medical preparations for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases, and veterinary pharmaceutical preparations for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; medical preparations, namely, adjuvants used in vaccines; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceuticals for the treatment of cancer and autoimmune disorders; drug delivery agents in the form of intravenous administration fluids that facilitate the delivery of pharmaceutical preparations; synthetic proteins and peptides for pharmaceutical and medical purposes, namely, for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; regulatory proteins and peptides for pharmaceutical and medical use, namely, protein arrays for treating cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases
1 Chemicals for use in industry and science; chemicals for use in manufacture of peptides, small molecules, and a wide variety of goods; biological preparations for use in industry and science; biological preparations for use in manufacture; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the pharmaceutical industry, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; chemicals and chemical preparations for use in biotechnological manufacturing processes; chemical and chemical preparations for use in biotechnological product development; chemicals and chemical preparations for use in the biotechnological industry; reagents for scientific purposes; reagents for medical research; enzymes for scientific purposes; enzymes for use in the manufacture of pharmaceuticals; biological preparations other than for medical use; proteins for use in industry and science; proteins for use in manufacture; peptides for use in industry and science; peptides for use in manufacture of pharmaceuticals
42 Design and development of computer hardware and software; clinical research in the field of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; medical and scientific research, namely, conducting clinical trials for others; drug discovery services; development of pharmaceutical preparations and medicines; research relating to medicines; medical and pharmacological research services; medical laboratories; scientific and technological services, namely, research and design in the field of medical technology; product design and development of medical apparatus; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to medical and veterinary research and development
"THERAPEUTICS"

Trademark Events
Apr 2, 2024
Notice Of Registration Confirmation Emailed
Apr 2, 2024
Registered-Principal Register
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Jan 13, 2024
Notification Processed By Ib
Dec 27, 2023
Notification Of Possible Opposition Sent To Ib
Dec 27, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 13, 2023
Approved For Pub - Principal Register
Nov 16, 2023
Teas/Email Correspondence Entered
Nov 16, 2023
Correspondence Received In Law Office
Nov 16, 2023
Teas Response To Office Action Received
Nov 13, 2023
Teas Change Of Correspondence Received
Nov 13, 2023
Teas Change Of Domestic Representatives Address
Nov 13, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 13, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 13, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 13, 2023
Teas Change Of Owner Address Received
Oct 6, 2023
New Representative At Ib Received
Jun 26, 2023
Refusal Processed By Ib
Jun 7, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jun 7, 2023
Refusal Processed By Mpu
Apr 18, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Apr 17, 2023
Non-Final Action Written
Apr 13, 2023
Assigned To Examiner
Mar 1, 2023
Application Filing Receipt Mailed
Feb 25, 2023
New Application Office Supplied Data Entered
Feb 24, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24